Search
Subasumstat
go.drugbank.com/drugs/DB16406InvestigationalSubasumstat is under investigation in clinical trial NCT03648372 (A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy and Pharmacokinetics (PK) of TAK-981 in Adult Participants With Advanced or Metastatic Solid Tumors or R...
1D09C3
go.drugbank.com/drugs/DB05121Experimental1D09C3, a monoclonal antibody against lymphoid cancers, is an anti-MHC (major histocompatibility complex) class II monoclonal antibody.
Bleomycin A6
go.drugbank.com/drugs/DB12992InvestigationalIt was developed in China as an antineoplastic antibiotic. This drug participated in clinical trials for the treatment of Squamous Cell Lung Cancer.
Taspoglutide
go.drugbank.com/drugs/DB14027InvestigationalIn September 2010 Roche halted Phase III clinical trials due to incidences of serious hypersensitivity reactions and gastrointestinal side effects. As of May 2013 no new trials had been registered.
Orludodstat
go.drugbank.com/drugs/DB21498InvestigationalOrludodstat has a monoisotopic molecular weight of 520.09 Da.
Revexepride
go.drugbank.com/drugs/DB20324InvestigationalRevexepride has a monoisotopic molecular weight of 425.21 Da.
Radequinil
go.drugbank.com/drugs/DB19722InvestigationalRadequinil has a monoisotopic molecular weight of 334.11 Da.
Levcromakalim
go.drugbank.com/drugs/DB21154InvestigationalLevcromakalim has a monoisotopic molecular weight of 286.13 Da.
Lepzacitinib
go.drugbank.com/drugs/DB21646InvestigationalLepzacitinib has a monoisotopic molecular weight of 355.16 Da.
Luvometinib
go.drugbank.com/drugs/DB21696InvestigationalLuvometinib has a monoisotopic molecular weight of 665.04 Da.